logo

For the Inventor, By the Inventor

Buenos Aires, Argentina

Viviana Parreno

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Instituto Nacional De Technologia Agropecuaria, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Viviana Parreno. Retrieved from https://idiyas.com/inventor/viviana-parreno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal3 out of 4 
 
Instituto Nacional De Technologia Agropecuaria
 patents
silverMedal3 out of 3,697 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
where one patent can have more than one assignee

Years Active: 2018-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 11325965 - Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use (2022-05-10),
2. 10662238 - Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use (2020-05-26),
3. 10000556 - [object Object] (2018-06-19),

Title: Viviana Parreno: Innovator in Norovirus Research

Introduction

Viviana Parreno is a prominent inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of virology, particularly in the study of noroviruses. With a total of three patents to her name, her work focuses on developing innovative solutions for detecting and treating norovirus infections.

Latest Patents

Viviana's latest patents include "Single-domain VH antibodies directed to norovirus GI.1 and GII.4 and their use." This patent discloses isolated VH monoclonal antibodies that specifically bind to a Norovirus polypeptide. The noroviruses addressed in her work include Genogroup I and Genogroup II Noroviruses, as well as specific strains such as Norwalk and MD2004 virus. The disclosed antibodies can be utilized for detecting the presence of norovirus in biological samples and for diagnosing norovirus infections. Additionally, her patents outline methods for treating and preventing norovirus infections.

Career Highlights

Throughout her career, Viviana has worked with notable organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and the Instituto Nacional de Tecnología Agropecuaria. Her work has been instrumental in advancing the understanding and management of norovirus-related health issues.

Collaborations

Viviana has collaborated with esteemed colleagues

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…